A: Clinical trials have shown that semaglutide (Wegovy) produces an average weight loss of approximately 15% of body weight over approximately 68 weeks, while tirzepatide (Zepbound) has demonstrated average weight reductions of up to 22%
Keep the dose, syringe pull, inventory, and next action ready at a glance
If something doesnt feel right during your injection, its not always about expiration sometimes the issue comes from the pen itself
1.4 Regulatory Status and Approved Indications Semaglutide-based therapies are approved in multiple jurisdictions for: Type 2 diabetes mellitus management Chronic weight management in obese or overweight individuals Cardiovascular risk reduction in select populations Approval frameworks emphasize both glycemic endpoints and broader cardiometabolic outcomes
Will you lose weight on semaglutide if you continue to sit on your couch, exercise, eat healthily, and not increase your water intake
It is associated with a mild form of carnitine palmitoyl transferase I deficiency, putting homozygous individuals at risk for fasting hypoglycemia 9,10
